Cardiovascular involvement of amyloidosis is present in 90% of cases, which is frequently associated with the primary form of the disease (AL amyloidosis). Clinical manifestations are represented by heart failure due to restrictive myocardiopathy and electrical impulse conduction abnormalities, which are clinically remarkable in up to 50% of the cases. The prognosis of patients with systemic amyloidosis is directly associated with the presence of cardiac involvement, such that survival does not usually exceed 4 months after the onset of heart failure signs and symptoms. The authors report a case of primary systemic amyloidosis, diagnosed only at autopsy, with severe cardiac involvement.
HassanW, Al-SerganiH, MouradW, TabbaaR. Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management. Tex Heart Inst J. 2005;32(2):178-84. [PMID:16107109].
García-PavíaP, Tomé-EstebanMT, RapezziC. [Amyloidosis. Also a heart disease]. Rev Esp Cardiol. 2011;64(9):797-808. [PMID:21775043].
EstepJD, BhimarajA, Cordero-ReyesAM, BrucknerB, LoebeM, Torre-AmioneG. Heart transplantation and end-stage cardiac amyloidosis: a review and approach to evaluation and management. Methodist Debakey Cardiovasc J. 2012;8(3):8-16. [PMID:23227279].
PodduturiV, ArmstrongDR, HitchcockMA, RobertsWC, GuileyardoJM. Isolated atrial amyloidosis and the importance of molecular classification. Proc (Bayl Univ Med Cent). 2013;26(4):387-9. [PMID:24082415].
ViswanathanG, WilliamsJ, SlinnS, CampbellP. Mitral valve involvement as a predominant feature of cardiac amyloidosis. BMJ Case Rep. 2010;1-5.
CostaT, MartinsV, MartinsY, PiresJ. Amiloidose e o aparelho respiratorio. Acta Med Port. 2009;22(1):105-12. [PMID:19341599].
Bonsib, SM.Non-neoplastic diseases of the kidney. In: BostwickDG, ChengL, editors. Urological surgical pathology. 2nd ed. London: Elsevier; 2008. p. 65.
VerineJ, MouradN, DesseauxK, et al. Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response. Hum Pathol. 2007;38(12):1798-809. [https://doi.org/10.1016/j.humpath.2007.04.013]. [PMID:17714761]
AmbrosyAP, GheorghiadeM, BubenekS, et al. The predictive value of transaminases at admission in patients hospitalized for heart failure: findings from the RO-AHFS registry. Eur Heart J Acute Cardiovasc Care. 2013;2(2):99-108. [https://doi.org/10.1177/2048872612474906]. [PMID:24222818]